AVITA Medical, Inc. (RCEL) Net Shares Issued and Repurchased (2021 - 2025)

AVITA Medical (RCEL) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $2.0 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased rose 3.25% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $2.0 million (up 3.25% YoY), and the FY2025 full-year result was $2.0 million, up 3.25% from the prior year.
• Net Shares Issued and Repurchased climbed to $2.0 million in Q4 2025 per RCEL's latest filing, from $1.2 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.0 million in Q4 2025 and bottomed at $21900.0 in Q1 2022.
• Historically, Net Shares Issued and Repurchased has averaged $795470.2 across 5 years, with a median of $737676.0 in 2022.
• The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased tumbled 90.23% in 2022, then soared 2768.49% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $186975.0 in 2021, then soared by 294.53% to $737676.0 in 2022, then soared by 31.79% to $972193.0 in 2023, then jumped by 99.82% to $1.9 million in 2024, then climbed by 3.25% to $2.0 million in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.0 million, $1.2 million, and $1.9 million for Q4 2025, Q1 2025, and Q4 2024 respectively.